Beyond the Blood Bank: When Transfusion Medicine Reaches the Bedside
This Apheresis Awareness Day, sharing, a post about - Apheresis, Clinical transfusion medicine, and the privilege of being part of a patient's journey towards recovery!
What does a Transfusion Medicine consultant do?
If you ask this question, the answer that most people would probably give is:
“They manage the blood bank.”
And that answer is not wrong.
Blood banking is the foundation of Transfusion Medicine. Blood grouping, compatibility testing, component preparation, transfusion support, immunohematology and blood safety remain fundamental to what we do.
But Transfusion Medicine has evolved far beyond the traditional blood bank.
Into the ICU.
To the bedside.
Beside an apheresis machine.
And right into the heart of clinical decision-making.
Working alongside neurologists, intensivists, nurses and other members of the clinical team to help a patient recover.
One such experience from the apheresis unit stayed with me.
And on Apheresis Awareness Day, it feels especially meaningful to share it.
The Case - When weakness changes everything !
An elderly gentleman presented with a dramatic neurological deterioration.
He had developed severe weakness involving all four limbs, with profound loss of power and muscle tone. From being functionally independent, he had become bedridden and almost completely dependent on others.
For the patient, this was a frightening loss of independence.
For his family, watching someone who had previously been functional suddenly become unable to move normally was understandably distressing.
The treating physician and his team undertook evaluation and the patient was diagnosed with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).
As part of his multidisciplinary treatment, Therapeutic Plasma Exchange (TPE), also known as plasma exchange or PLEX, was undertaken.
The elderly gentleman had gone from being functional to being profoundly weak and bedridden.
For the family, there was a person they knew who had suddenly lost much of his independence.
For the treating team, there was an urgent clinical problem to address.
For me, this case was a reminder of something that is easy to forget when we think of Transfusion Medicine only through the lens of blood components:
Our knowledge of blood can sometimes be used not to give something to a patient, but to therapeutically remove something from their circulation.
And that is where apheresis becomes fascinating.
What is CIDP?
Before understanding the role of plasma exchange, it is important to understand the underlying disease.
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, or CIDP, is an immune-mediated disorder affecting the peripheral nervous system.
The peripheral nerves carry signals between the brain, spinal cord and the rest of the body.
These nerves are surrounded by myelin, a specialized insulating layer that helps electrical signals travel efficiently.
In CIDP, an abnormal immune response causes inflammation and damage involving peripheral nerves and their myelin.
The clinical manifestations can include:
Progressive or relapsing muscle weakness
Difficulty walking
Loss or reduction of reflexes
Sensory disturbances
Problems with balance
Difficulty using the hands
Functional disability
The presentation and severity can vary considerably between patients.
Importantly, CIDP is a clinical diagnosis supported by investigations such as electrophysiological studies and appropriate exclusion of alternative diagnoses.
This matters because therapeutic plasma exchange is not a treatment for “weakness” itself.
It is a specialized therapy used when the underlying clinical diagnosis and treatment strategy make it appropriate.
So, where does plasma exchange come in?
This is where the biology of plasma becomes clinically important.
Most people associate plasma with the yellow-coloured liquid component of blood.
But plasma is much more than a fluid.
It contains a complex mixture of proteins and other substances, including:
Antibodies
Albumin
Coagulation proteins
Complement components
Hormones
Cytokines
Other circulating biologically active substances
In certain diseases, pathological antibodies or other disease-associated substances circulating in plasma may contribute to the disease process.
This leads to a simple therapeutic concept:
What if we could remove some of these circulating factors?
That is one of the principles behind Therapeutic Plasma Exchange.
During TPE, the patient's blood is circulated through an apheresis machine.
TPE removes the patient's plasma while returning their cellular blood components.
The objective is not simply to “clean the blood.”
Rather, the purpose is to reduce the circulating concentration or burden of disease-associated substances when plasma exchange is an appropriate therapeutic strategy.
This is what makes therapeutic apheresis different from simply removing blood.
We are using technology to manipulate specific components of blood in a controlled therapeutic manner.
PLEX is not simply “connecting a patient to a machine”
But PLEX is much more than connecting a patient to a machine.
The machine performs the separation.
The apheresis team decides why, when and how that separation should be used.
And that distinction matters.
Before the procedure, the apheresis team needs to consider:
Patient selection
Is the diagnosis appropriate?
Is TPE indicated?
What is the intended therapeutic goal?
What other treatments has the patient received?
Vascular access
What type of vascular access is appropriate for this patient?
Will adequate blood flow be maintained safely throughout the procedure?
Anticoagulation
The extracorporeal circuit requires anticoagulation.
The team must balance the need to prevent clotting in the circuit with the patient's individual bleeding and coagulation risks.
Replacement fluid
What should replace the removed plasma?
Depending on the clinical indication and circumstances, replacement may involve albumin-based fluids, plasma or other appropriate solutions.
Calcium and electrolytes
Citrate-based anticoagulation can affect ionised calcium levels.
Patients therefore require appropriate monitoring and management, including calcium supplementation when indicated.
Haemodynamic monitoring
The procedure involves extracorporeal circulation and removal/replacement of plasma.
Blood pressure, heart rate, symptoms and overall tolerance therefore need to be monitored carefully.
Coagulation
Plasma exchange can remove coagulation proteins along with other plasma constituents.
Coagulation parameters and the patient's clinical situation must therefore be considered, particularly when repeated procedures are planned.
Complication management
The team must be prepared to recognise and manage complications such as citrate-related symptoms, hypotension, allergic reactions and other procedure-related events.
And finally:
Clinical response
The most important question remains:
Is the patient improving?
This is why therapeutic apheresis is much more than operating a sophisticated machine.
The machine performs the separation.The clinical team provides the clinical reasoning.
TPE in CIDP
The treatment of CIDP is aimed at controlling the abnormal immune-mediated process.
Current clinical guidance recognises intravenous immunoglobulin (IVIg), corticosteroids and plasma exchange as important treatment options, with the choice depending on the clinical circumstances.
Plasma exchange has an established role in CIDP, particularly when initial therapies such as IVIg and corticosteroids are ineffective or unsuitable.
The precise treatment strategy must always be individualised according to the patient's diagnosis, severity, previous treatment, comorbidities and clinical response.
This is an important distinction.
TPE is not performed simply because a patient is severely weak.
The decision requires an appropriate diagnosis, an evidence-based indication and careful integration into the overall treatment plan.
Coming back to our patient
This is where the science became personal.
Because behind every procedure sheet, every exchanged volume and every number on the monitor is a person hoping to get back to their life.
TPE was undertaken as part of his multidisciplinary management.
The procedure required careful monitoring and coordination.
But the most memorable part of the experience came afterwards.
With therapeutic intervention and ongoing multidisciplinary care, the patient showed remarkable clinical improvement, with substantial restoration of power and improvement in muscle tone.
Almost all of his power was restored.
For an apheresis physician, this is one of those moments that stays with you.
Because the machine shows numbers.
The procedure record shows volumes.
The monitor shows pressures and flow rates.
But the patient shows you something much more meaningful:
Movement.
A hand moving.
A limb responding.
Muscle tone returning.
A person beginning to regain some of the independence that illness had taken away.
And sometimes, movement means hope.
The most rewarding part isn't the machine
The apheresis machine may be the most visible piece of technology in the room.
It is sophisticated.
It is precise.
It can separate blood components with remarkable efficiency.
But when I look at an apheresis, I don't primarily see a machine.
I see a patient.
I see a clinical problem.
I see a team.
I see science being translated into patient care.
And I see the possibility of recovery.
Behind every number on a monitor is a patient.
And behind every successful intervention is a team.
The apheresis physician is not simply the person operating the machine
Apheresis technology is sophisticated.
But technology alone does not make therapeutic apheresis successful.
The Apheresis physician needs to understand the disease.
And they require more than technical knowledge.
They require clinical apheresis expertise.
🩸 This is what “Beyond the Blood Bank” means to me.
Transfusion Medicine should not be confined to the four walls of the blood bank.
The neurologist brings expertise in the neurological disease.
The intensivist and clinical team manage the patient's overall condition.
The nursing team provides continuous bedside care.
The laboratory supports diagnosis and monitoring.
And the Transfusion Medicine/apheresis team contributes expertise in extracorporeal blood component manipulation and therapeutic apheresis.
It is truly multidisciplinary medicine.
And the patient remains at the centre.
A message to young Transfusion Medicine professionals
To all young Transfusion Medicine professionals:
Don't let the words “blood bank” define the limits of our specialty.
Learn blood banking. Master immunohematology. Understand blood components.
But then—go beyond. Today, the specialty encompasses a much broader clinical landscape.
Explore:
🔄 Therapeutic apheresis
🧬 Cellular therapy
🩺 Patient Blood Management
🛡️ Haemovigilance
🔬 Clinical transfusion support
🩸 Advanced Immunohematology
🌱 Stem-cell collection and processing
🧪 Complex transfusion support
Go to the bedside.
Talk to treating physicians.
Understand their patients.
Ask why a particular intervention is being considered.
Discover where your expertise can change a clinical decision.
Because there is a profound difference between providing a laboratory service and providing clinical care.
Therapeutic apheresis is one of the clearest examples of this evolution.
It takes the Transfusion Medicine specialist directly to the patient's bedside.
The beauty of multidisciplinary medicine
One of the aspects I value most about therapeutic apheresis is how naturally it brings different specialties together.
The neurologist understands the underlying neurological disease.
The intensivist and treating physicians manage the patient's overall clinical condition.
The nursing team provides continuous monitoring and bedside care.
The laboratory contributes diagnostic and monitoring information.
And the Transfusion Medicine/apheresis team brings expertise in extracorporeal blood component manipulation and therapeutic apheresis.
No single specialty works in isolation.
The patient is at the centre.
And that is exactly where Transfusion Medicine belongs.
At the centre of patient care—not merely at the centre of blood processing.
On Apheresis Awareness Day
Today, 15 September 2026, marks Apheresis Awareness Day, an occasion to recognise the contribution of apheresis to modern medicine and to honour the patients, donors and healthcare professionals who make this field possible.
Apheresis is a beautiful intersection of technology, physiology, immunology and clinical medicine.
But at its heart, it remains about people.
The patient who needs help.
The donor who makes certain therapies possible.
The nurse monitoring every minute of a procedure.
The technologist ensuring the system works safely.
The physician making clinical decisions.
And the multidisciplinary team working towards one common goal:
better patient care.
Happy Apheresis Awareness Day 2026. ❤️
I am grateful to have been a small part of this patient's journey.
Grateful for the science that makes therapeutic apheresis possible.
Grateful for the technology that allows us to manipulate blood components therapeutically.
Grateful for the multidisciplinary team.
And most importantly, grateful for the privilege of contributing directly to patient care.
Because perhaps this is one of the most beautiful things about Transfusion Medicine:
We don't just manage blood. We use our understanding of blood to help people.
And sometimes, that means helping a patient find their movement—
and their hope—again. ❤️🔄
And that is where the art and science of clinical Transfusion Medicine truly meet.
Disclaimer : A note about this clinical experience
This is an educational account based on a clinical experience. Patient-identifying information has been omitted to protect confidentiality.
The clinical improvement described occurred in the context of multidisciplinary management and should not be interpreted as evidence that plasma exchange alone caused the outcome.
Therapeutic plasma exchange is a specialised therapy that should be undertaken only when clinically indicated, using an appropriate evidence-based approach and in an adequately equipped centre with trained personnel.
Yours Truly,
Dr Ruchi Punamia,
Founder and Author,
The Blood Blog
(The Blood Community for All)
Join the blood blog community and #DonateSafeBlood campaign.
Follow us on all our social media handles.
Tap on the link now.
https://www.hopp.bio/thebloodblog
Let's spread the word and unite for blood wellness and awareness.
Thank you for being a part of "The Blood Blog" family.
Here's to the life-sustaining, community-binding, and awe-inspiring world of blood!
Comments